Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,928.00    36.00 (1.90%)
Bid:
1,912.00
Ask:
1,914.00
Spread: 2.00 (0.105%)
Market Cap: £3.24b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Johnson Matthey Battery Materials update

12 Jan 2022 14:19

RNS Number : 2549Y
Johnson Matthey PLC
12 January 2022
 

12th January 2022

 

Johnson Matthey Plc

(the Company)

Johnson Matthey provides an update on its intention to exit Battery Materials

 

Johnson Matthey, a global leader in sustainable technologies, today provides an update on its intention to exit Battery Materials.

 

On 11th November 2021, we announced our intention to pursue the sale of all or parts of our Battery Materials business with the ultimate intention of exiting. Further to that announcement, we have held discussions with a number of parties about a sale of the entire business. These discussions have not resulted in an agreement to sell the entire business as a going concern. Consequently, we are announcing today that we are commencing consultation with our employees about our proposed closure of the Battery Materials business, and we are pursuing the sale of its individual assets.

 

In our interim results we fully impaired the carrying value of our battery materials assets as at 30th September 2021, resulting in a charge of £314 million. While the outcome of the sales process is uncertain, full or partial closure will result in additional impairment charges, the settlement of contractual liabilities, redundancy, closure and abandonment costs as we indicated at our interim results on 24th November 2021. After anticipated asset disposal proceeds, we currently estimate these cash costs will be in the order of £150 million, which will be recorded as an exceptional item outside of underlying operating profit in our full year results.

 

 

ENDS

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

Media

Barney Wyld

Harry Cameron

 

 

Group Corporate Affairs Director

Tulchan Communications

 

 

+44 7485 337498

+44 20 7353 4200

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEALFAFFXAEFA
Date   Source Headline
9th Aug 20211:52 pmRNSDirector/PDMR Shareholding
6th Aug 202111:45 amRNSHolding(s) in Company
5th Aug 20212:47 pmRNSDirector/PDMR Shareholding
5th Aug 202112:17 pmRNSDirector/PDMR Shareholding
5th Aug 202112:13 pmRNSDirector/PDMR Shareholding
5th Aug 202112:06 pmRNSDirector/PDMR Shareholding
5th Aug 202111:43 amRNSDirector/PDMR Shareholding
4th Aug 20214:22 pmRNSDirector/PDMR Shareholding
4th Aug 20214:08 pmRNSDirector/PDMR Shareholding
4th Aug 20213:51 pmRNSDirector/PDMR Shareholding
4th Aug 20213:34 pmRNSDirector/PDMR Shareholding
2nd Aug 20213:45 pmRNSHolding(s) in Company
30th Jul 20214:15 pmRNSHolding(s) in Company
29th Jul 202112:40 pmRNSResult of AGM
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSJohnson Matthey Q1 AGM trading update
22nd Jul 20214:24 pmRNSDirector/PDMR Shareholding
13th Jul 20215:39 pmRNSHolding(s) in Company
12th Jul 20214:05 pmRNSHolding(s) in Company
9th Jul 20215:01 pmRNSHolding(s) in Company
21st Jun 20213:15 pmRNSHolding(s) in Company
18th Jun 20213:54 pmRNSHolding(s) in Company
17th Jun 20213:56 pmRNSDirector/PDMR Shareholding
15th Jun 20219:00 amRNSAnnual Financial Report
10th Jun 20214:15 pmRNSHolding(s) in Company
27th May 20217:04 amRNSPreliminary results for year ended 31st March 2021
26th May 20217:00 amRNSJohnson Matthey and Plug Power green hydrogen MoU
20th May 202111:34 amRNSDirector/PDMR Shareholding
23rd Apr 20219:51 amRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSStrategic developments in eLNO commercialisation
9th Apr 20214:10 pmRNSHolding(s) in Company
8th Apr 202111:10 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading update and strategic review of Health
24th Mar 202111:14 amRNSHolding(s) in Company
19th Mar 20213:00 pmRNSHolding(s) in Company
18th Mar 202111:53 amRNSDirector/PDMR Shareholding
9th Mar 20214:40 pmRNSHolding(s) in Company
8th Mar 202112:20 pmRNSHolding(s) in Company
24th Feb 20214:17 pmRNSDirector/PDMR Shareholding
18th Feb 20213:45 pmRNSDirector/PDMR Shareholding
16th Feb 20219:15 amRNSHolding(s) in Company
12th Feb 202110:15 amRNSHolding(s) in Company
8th Feb 20212:14 pmRNSDirector/PDMR Shareholding
8th Feb 20212:02 pmRNSDirector/PDMR Shareholding
22nd Jan 20214:15 pmRNSHolding(s) in Company
22nd Jan 202110:31 amRNSDirector/PDMR Shareholding
12th Jan 20217:00 amRNSAppointment of Chief Financial Officer
18th Dec 20203:29 pmRNSDirector/PDMR Shareholding
20th Nov 20202:55 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSJohnson Matthey half year results 30 Sept 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.